Brief: Phio Pharma Expects Current Cash Will Be Sufficient To Fund Currently Planned Operations To Q2 Of 2023
25/03/2021 21:56
March 25 (Reuters) - Phio Pharmaceuticals Corp PHIO.O :
* PHIO PHARMACEUTICALS REPORTS 2020 YEAR END FINANCIAL
RESULTS AND
PROVIDES BUSINESS UPDATE
* PHIO PHARMACEUTICALS CORP - AT DECEMBER 31, 2020, COMPANY
HAD
CASH OF $14.2 MILLION
* PHIO PHARMACEUTICALS CORP - EXPECTS CURRENT CASH WILL BE
SUFFICIENT TO FUND CURRENTLY PLANNED OPERATIONS TO Q2 OF 2023
Source text for Eikon: ID:nPn5V19zKa
Further company coverage: PHIO.O
((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))
Recent news on Phio Pharmaceuticals
See all newsPhio Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: Phio Pharmaceuticals Corp - Enters At The Market Offering Agreement With H.C. Wainwright On April 8, 2026
Brief: Phio Pharmaceuticals Corp Announces Key Tumor Response Data From PH-762 Trial
Brief: Phio Pharmaceuticals Corp To Begin Toxicology Study For Ph-762 Before Human Trials - SEC Filing
Brief: Phio Pharmaceuticals Corp Files For Offering Of Up To 11.8 Million Common Shares By The Selling Stockholders - SEC Filing